18 June 2025 in Journal of Hepatology
25 June 2025 in Medical Care
Background: Nurses are integral to patient care in US hospitals, yet high burnout rates exacerbated by staffing shortages and the COVID-19 pandemic pose challenges in retaining nursing staff. Understanding staffing dynamics and trends in the care team composition is vital to improve care and address the well-being of the health care workforce. Objective: To examine trends in employment and compensation among registered nurses (RNs), physicians, nurse practitioners (NPs), physician assistants (PAs), medical assistants (MAs), licensed practical and vocational nurses (LPN/LVNs), and administrative staff from 2012 to 2022. Methods: Data from the Occupational Employment and Wage Statistics (OEWS) was utilized to analyze employment and wage trends in hospitals and physician offices. The annual RN-to-physician, NP-to-physician, and PA-to-physician ratios and change in employment and compensation over time were calculated. Results: Although hospital RN employment increased by 12%, this was outpaced by physician (40%), NP (105%), PA (38%), and MA (44%) employment growth. The hospital RN-to-physician ratio declined by 21%, whereas the NP-to-physician and PA-to-physician ratios increased by 46% and 28%, respectively. In offices, the NP-to-physician ratio increased by 107%, whereas the RN-to-physician ratio remained stable. Wage growth for all clinical hospital staff increased around 30%, while physicians saw wage growth of 43%. Discussion: The declining RN-to-physician ratio in hospitals signals a shift in the care team composition. While APP employment has drastically risen, RN growth has lagged significantly behind. Urgent action is needed to optimize staffing strategies to safeguard patient care.
28 May 2025 in Journal of Hepatology
FGFatty Liver in Pregnancy (FLIP) Study Group
Fatty Liver in Pregnancy (FLIP) Study Group
31 July 2025 in American Journal of Gastroenterology
INTRODUCTION: Hepatitis delta virus (HDV) is the most aggressive form of viral hepatitis, yet screening rates in the United States are low, and few institutions have attempted interventions to improve the screening cascade. We assessed barriers to reflex test implementation, including lack of a Food and Drug Administration-approved reflex test, and implemented hepatitis B surface antigen (HBsAg) to HDV antibody (HDV Ab) reflex testing in our large, urban, academic healthcare system. METHODS: We evaluated outcomes 1 year after implementation using summary statistics. Patient-level and clinic-level characteristics were investigated for association with receiving a reflex test vs standalone HBsAg test using multivariable logistic regression. RESULTS: All patients with a reflex order and HBsAg-positive result received HDV Ab follow-up testing, and their time to HDV Ab result was significantly shorter than those whose HDV test required a separate order (2 vs 11 days, P < 0.0001). Uptake of the reflex order was highest in primary care, where it was embedded into existing workflows. DISCUSSION: Reflex testing improved efficiency and reduced gaps in the HBsAg to HDV screening cascade. Disparities in reflex testing rates among different patient groups were found, highlighting the need for universal reflex testing.
7 March 2025 in Surgical Oncology
24 November 2025 in American Journal of Gastroenterology
INTRODUCTION: Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease of pregnancy, varying in incidence based on population and associated with adverse outcomes. We assessed the prevalence and outcomes of ICP categories defined by the 2023 European Association for the Study of the Liver guidelines in a diverse US population. METHODS: We conducted a retrospective cohort study (January 2009–April 2024) at our ethnically diverse health system. Suspected ICP patients were identified by pregnancy records with total serum bile acids (TSBA) ordered and categorized into Group A (normal TSBA, alanine aminotransferase [ALT]/aspartate aminotransferase [AST]), B (elevated ALT/AST, normal TSBA), or C (TSBA >19, normal or elevated ALT/AST). RESULTS: Among 165,503 pregnancies, we identified 4,386 (3.6%) suspected ICP cases. The cohort was classified as A (65%), B (24%), or C (11%). On multivariable analysis, a pre-existing history of autoimmune disease, metabolic dysfunction-associated steatotic liver disease, and gestational hypertension were significantly associated with Group B compared with A. Group C was more strongly associated with Hispanic ethnicity, history of hepatitis C, and immune-mediated liver diseases. Preeclampsia was 3 times as common in Groups B and C compared with A. Group C had the highest odds of spontaneous preterm birth, meconium-stained amniotic fluid, and neonatal respiratory distress. Group B and C had higher rates of incident postpartum hepatobiliary diseases. DISCUSSION: Our systematic evaluation of the 2023 European Association for the Study of the Liver guidelines for suspected ICP demonstrated that this novel group-based classification offers clinically meaningful risk stratification. Our findings support that both elevated TSBA (Group C) and elevated ALT/AST alone (Group B) warrant antepartum surveillance for adverse pregnancy outcomes. Group C's association with Hispanic ethnicity and pre-existing liver disease highlights the need for individualized monitoring during pregnancy. Group-specific increased incidence of postpregnancy hepatobiliary disease emphasizes the importance of targeted postpartum follow-up.